Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes?
Featuring
Professor Subodh Verma | Canada
Professor Soo Yong Lee | Korea
Related content
Document ID: PC-MY-103756
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
Clinical relationship between the heart and the kidneys
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
How has recent evidence and the ESC 2023 guidelines changed management of heart failure?
Theresa McDonagh (United Kingdom)
What's new for the treatment of chronic heart failure from the ESC 2023 guidelines?
Heart Failure 360: Early protection for every heart failure patient
02:13:04